CVS has emerged as an outlier during the ongoing implosion observed in the healthcare insurance sector, as they drive ...

Last week's consumer and producer price data "revived [the] stickiness of inflation debate, he says. While jobless claims were subdued, a nonfarm payrolls report at the start of August showed the ...

This investment signifies Buffett's re-entry into UNH after liquidating his entire position back in 2010, indicating that he perceives significant value at ...

Merck’s strong oncology gains, 4% yield, and low PEG ratio support its value case despite sector risks and patent concerns.

If any investor has stood the test of time, it is Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has ...

Shares of UnitedHealth Group Inc. (NYSE: UNH) climbed 2.81% in Monday's pre-market trading session, extending Friday's gain ...

UnitedHealth Group Incorporated stocks jumped sharply, riding a wave of investor enthusiasm. Berkshire Hathaway's new $1.57B ...

UnitedHealth Group Incorporated (NYSE:UNH) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On August 7, Mizuho analyst Ann Hynes kept her “Buy” rating, expecting long-term value despite ...

Berkshire Hathaway recently filed its second-quarter 13F form, revealing its stock holdings at the end of June.